4.8 Article

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

Journal

NATURE BIOTECHNOLOGY
Volume 31, Issue 3, Pages 230-232

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2507

Keywords

-

Funding

  1. National Research Foundation of Korea [2012-0001225]
  2. ToolGen, Inc.
  3. National Research Foundation of Korea [2010-0018267] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

We employ the CRISPR-Cas system of Streptococcus pyogenes as programmable RNA-guided endonucleases (RGENs) to cleave DNA in a targeted manner for genome editing in human cells. We show that complexes of the Cas9 protein and artificial chimeric RNAs efficiently cleave two genomic sites and induce indels with frequencies of up to 33%.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available